Overexpression of Tumour Necrosis Factor-α-Induced Protein 8 is Associated with Prognosis in Colon Cancer

References

• Keum NN, Giovannucci E. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat Rev Gastroenterol Hepatol. 2019;16(5).
   PubMedGoogle Scholar
• Siegel R, Miller K, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34. doi:10.3322/caac.2155130620402
   PubMed Web of Science ®Google Scholar
• Siegel R, Miller K, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30. doi:10.3322/caac.2159031912902
   PubMed Web of Science ®Google Scholar
• Zhang L, Cao F, Zhang G, et al. Trends in and predictions of colorectal cancer incidence and mortality in China from 1990 to 2025. Front Oncol. 2019;9:98. doi:10.3389/fonc.2019.0009830847304
   PubMed Web of Science ®Google Scholar
• Siegel R, Miller K, Goding Sauer A, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020;70(3):145–164. doi:10.3322/caac.2160132133645
   PubMed Web of Science ®Google Scholar
• Qiu M, Pan W, Lin J, et al. Comparison of survival between right-sided and left-sided colon cancer in different situations. Cancer Med. 2018;7(4):1141–1150. doi:10.1002/cam4.140129533001
   PubMed Web of Science ®Google Scholar
• Imperial R, Ahmed Z, Toor O, et al. Comparative proteogenomic analysis of right-sided colon cancer, left-sided colon cancer and rectal cancer reveals distinct mutational profiles. Mol Cancer. 2018;17(1):177. doi:10.1186/s12943-018-0923-930577807
   PubMed Web of Science ®Google Scholar
• Petrelli F, Tomasello G, Borgonovo K, et al. Prognostic survival associated with left-sided vs right-sided colon cancer: a systematic review and meta-analysis. JAMA oncol. 2017;3(2):211–219. doi:10.1001/jamaoncol.2016.422727787550
   PubMed Web of Science ®Google Scholar
• Baig N, Li Z, Lu J, et al. Clinical significance and comparison of flotillin 1 expression in left and right colon cancer. Oncol Lett. 2019;18(2):997–1004. doi:10.3892/ol.2019.1040131423159
   PubMed Web of Science ®Google Scholar
• Wang Q, Zhang M, Shi C, et al. High Oct4 predicted worse prognosis of right-sided colon cancer patients. Future Oncol. 2018;14(22):2279–2291. doi:10.2217/fon-2018-004629656661
   PubMed Web of Science ®Google Scholar
• Hussain M, Waqas O, Hassan U, et al. Right-sided and left-sided colon cancers are two distinct disease entities: an analysis of 200 cases in Pakistan. Asian Pac J Cancer Prev. 2016;17(5):2545–2548.27268627
   PubMedGoogle Scholar
• Yaeger R, Chatila W, Lipsyc M, et al. Clinical sequencing defines the genomic landscape of metastatic colorectal cancer. Cancer Cell. 2018;33(1):125–136.e3. doi:10.1016/j.ccell.2017.12.00429316426
   PubMed Web of Science ®Google Scholar
• Nawa T, Kato J, Kawamoto H, et al. Differences between right- and left-sided colon cancer in patient characteristics, cancer morphology and histology. J Gastroenterol Hepatol. 2008;23(3):418–423. doi:10.1111/j.1440-1746.2007.04923.x17532785
   PubMed Web of Science ®Google Scholar
• Karim S, Brennan K, Nanji S, Berry S, Booth C. Association between prognosis and tumor laterality in early-stage colon cancer. JAMA Oncol. 2017;3(10):1386–1392. doi:10.1001/jamaoncol.2017.101628594974
   PubMed Web of Science ®Google Scholar
• Patel S, Wang F, Whiteside T, Kasid U. Identification of seven differentially displayed transcripts in human primary and matched metastatic head and neck squamous cell carcinoma cell lines: implications in metastasis and/or radiation response. Oral Oncol. 1997;33(3):197–203. doi:10.1016/s0964-1955(96)00065-69307729
   PubMed Web of Science ®Google Scholar
• Kumar D, Gokhale P, Broustas C, Chakravarty D, Ahmad I, Kasid U. Expression of SCC-S2, an antiapoptotic molecule, correlates with enhanced proliferation and tumorigenicity of MDA-MB 435 cells. Oncogene. 2004;23(2):612–616. doi:10.1038/sj.onc.120712314724590
   PubMed Web of Science ®Google Scholar
• Niture S, Dong X, Arthur E, et al. Oncogenic role of tumor necrosis factor α-induced protein 8 (TNFAIP8). Cells. 2018;8(1):9. doi:10.3390/cells8010009
   PubMed Web of Science ®Google Scholar
• Niture S, Gyamfi M, Lin M, et al. TNFAIP8 regulates autophagy, cell steatosis, and promotes hepatocellular carcinoma cell proliferation. Cell Death Dis. 2020;11(3):178. doi:10.1038/s41419-020-2369-432152268
   PubMed Web of Science ®Google Scholar
• Xiao Y, Huang S, Qiu F, et al. Tumor necrosis factor α-induced protein 1 as a novel tumor suppressor through selective downregulation of CSNK2B blocks nuclear factor-κB activation in hepatocellular carcinoma. EBioMedicine. 2020;51:102603. doi:10.1016/j.ebiom.2019.10260331901862
   PubMed Web of Science ®Google Scholar
• Li Z, Zhang W, Li Y, et al. TIPE2 acts as a biomarker for GIST risk category and suppresses the viability and invasiveness of GIST cells. Cell Biosci. 2018;8(1):62. doi:10.1186/s13578-018-0261-z30534358
   PubMed Web of Science ®Google Scholar
• Fayngerts S, Wu J, Oxley C, et al. TIPE3 is the transfer protein of lipid second messengers that promote cancer. Cancer Cell. 2014;26(4):465–478. doi:10.1016/j.ccr.2014.07.02525242044
   PubMed Web of Science ®Google Scholar
• Zhong M, Zhu M, Liu Y, et al. TNFAIP8 promotes the migration of clear cell renal cell carcinoma by regulating the EMT. J Cancer. 2020;11(10):3061–3071. doi:10.7150/jca.4019132226521
   PubMed Web of Science ®Google Scholar
• Moniz L, Vanhaesebroeck B. A new TIPE of phosphoinositide regulator in cancer. Cancer Cell. 2014;26(4):443–444. doi:10.1016/j.ccell.2014.09.01725314070
   PubMed Web of Science ®Google Scholar
• Zhang L, Liu R, Luan Y, Yao Y. Tumor necrosis factor-α induced protein 8: pathophysiology, clinical significance, and regulatory mechanism. Int J Biol Sci. 2018;14(4):398–405. doi:10.7150/ijbs.2326829725261
   PubMed Web of Science ®Google Scholar
• Weiser M. AJCC 8th Edition: colorectal Cancer. Ann Surg Oncol. 2018;25(6):1454–1455. doi:10.1245/s10434-018-6462-129616422
   PubMed Web of Science ®Google Scholar
• Araújo R, Lira G, Vilaça J, et al. Prognostic and diagnostic implications of MMP-2, MMP-9, and VEGF-α expressions in colorectal cancer. Pathol Res Pract. 2015;211(1):71–77. doi:10.1016/j.prp.2014.09.00725446246
   PubMed Web of Science ®Google Scholar
• Padmavathi G, Banik K, Monisha J, et al. Novel tumor necrosis factor-α induced protein eight (TNFAIP8/TIPE) family: functions and downstream targets involved in cancer progression. Cancer Lett. 2018;432:260–271. doi:10.1016/j.canlet.2018.06.01729920292
   PubMed Web of Science ®Google Scholar
• Goldsmith J, Fayngerts S, Chen Y. Regulation of inflammation and tumorigenesis by the TIPE family of phospholipid transfer proteins. Cell Mol Immunol. 2017;14(6):482–487. doi:10.1038/cmi.2017.428287114
   PubMed Web of Science ®Google Scholar
• Sun Z, Liu X, Song J, et al. TNFAIP8 overexpression: a potential predictor of lymphatic metastatic recurrence in pN0 esophageal squamous cell carcinoma after Ivor Lewis esophagectomy. Tumour Biol. 2016;37(8):10923–10934. doi:10.1007/s13277-016-4978-126886285
   PubMedGoogle Scholar
• Yang M, Zhao Q, Wang X, et al. TNFAIP8 overexpression is associated with lymph node metastasis and poor prognosis in intestinal-type gastric adenocarcinoma. Histopathology. 2014;65(4):517–526. doi:10.1111/his.1241324621012
   PubMed Web of Science ®Google Scholar
• Zhong M, Li N, Qiu X, et al. TIPE regulates VEGFR2 expression and promotes angiogenesis in colorectal cancer. Int J Biol Sci. 2020;16(2):272–283. doi:10.7150/ijbs.3790631929755
   PubMed Web of Science ®Google Scholar
• Yang C, Xu W, Meng X, Zhou S, Zhang M, Cui D. SCC-S2 facilitates tumor proliferation and invasion via activating Wnt signaling and depressing hippo signaling in colorectal cancer cells and predicts poor prognosis of patients. J Histochem Cytochem. 2019;67(1):65–75. doi:10.1369/002215541879995730216108
   PubMed Web of Science ®Google Scholar
• Zhong M, Chen Z, Yan Y, et al. Expression of TIPE family members in human colorectal cancer. Oncol Lett. 2021;21(2):118. doi:10.3892/ol.2020.1237933376549
   PubMed Web of Science ®Google Scholar
• Lowe J, Nguyen T, Grimm S, et al. The novel p53 target TNFAIP8 variant 2 is increased in cancer and offsets p53-dependent tumor suppression. Cell Death Differ. 2017;24(1):181–191. doi:10.1038/cdd.2016.13027834950
   PubMed Web of Science ®Google Scholar
• Zhang C, Chakravarty D, Sakabe I, et al. Role of SCC-S2 in experimental metastasis and modulation of VEGFR-2, MMP-1, and MMP-9 expression. Mol Ther. 2006;13(5):947–955. doi:10.1016/j.ymthe.2005.11.02016455304
   PubMed Web of Science ®Google Scholar
• Liu K, Qin C, Wang Z, Liu S, Cui X, Zhang D. Expression of tumor necrosis factor-alpha-induced protein 8 in pancreas tissues and its correlation with epithelial growth factor receptor levels. Asian Pac J Cancer Prev. 2012;13(3):847–850. doi:10.7314/apjcp.2012.13.3.84722631659
   PubMedGoogle Scholar
• Shen H, Yang J, Huang Q, et al. Different treatment strategies and molecular features between right-sided and left-sided colon cancers. World J Gastroenterol. 2015;21(21):6470–6478. doi:10.3748/wjg.v21.i21.647026074686
   PubMed Web of Science ®Google Scholar
• Miao Z, Zhao T, Wang Z, et al. SCC-S2 is overexpressed in colon cancers and regulates cell proliferation. Tumour Biol. 2012;33(6):2099–2106. doi:10.1007/s13277-012-0469-122886548
   PubMedGoogle Scholar